Taiko Pharmaceutical Co.,Ltd.
4574
Rank in Stocks
#20517
Taiko Pharmaceutical Co.,Ltd. operates primarily in the pharmaceutical sector... Taiko Pharmaceutical Co.,Ltd. operates primarily in the pharmaceutical sector and the field of infection prevention. The company manufactures and distributes various over-the-counter medications, including its well-known Seirogan and Seirogan Toi-A brands, which are formulated to alleviate symptoms such as loose stools, diarrhea, vomiting, and ailments stemming from food or water contamination. Additionally, it provides specific tablets for diarrhea relief and quasi-pharmaceuticals like the Trumpet Intestinal Regulator BF. In its infection control segment, Taiko Pharmaceutical produces and supplies a range of sanitation products under the Cleverin brand to wholesalers. This includes the Cleverin generator, a device engineered to emit low concentrations of chlorine dioxide gas. The company also leverages its proprietary Cleverin technology by supplying it through original equipment manufacturer (OEM) agreements and engaging in joint product development ventures with other businesses. Its products are exported to several countries, including the United States, Canada, Thailand, Vietnam, Malaysia, and Mongolia. Taiko Pharmaceutical Co.,Ltd. was founded in 1946 and is headquartered in Osaka, Japan.
Share Price
$1.65
Last synced: 2026-11-10
Market Cap
$83.11M
Change (1 day)
0.38%
Change (1 year)
-9.10%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Taiko Pharmaceutical Co.,Ltd. (4574)
Category
Healthcare
Operating Margin for Taiko Pharmaceutical Co.,Ltd. (4574)
Operating Margin as of November 2026 TTM: 6.48%
According to Taiko Pharmaceutical Co.,Ltd.'s latest financial reports, its current operating margin (TTM) is 6.48%. At the end of 2025 the company had an operating margin of 7.18%.
Operating Margin history for Taiko Pharmaceutical Co.,Ltd. from 2007 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 6.48% | -9.75% |
| 2025 | 7.18% | -28.20% |
| 2024 | 10.00% | -160.90% |
| 2023 | -16.42% | -73.12% |
| 2022 | -61.09% | 32.34% |
| 2021 | -46.16% | -244.43% |
| 2020 | 31.96% | 63.39% |
| 2019 | 19.56% | -0.61% |
| 2018 | 19.68% | 5.52% |
| 2017 | 18.65% | 14.77% |
| 2016 | 16.25% | -41.34% |
| 2015 | 27.70% | 5.52% |
| 2014 | 26.25% | 73.61% |
| 2013 | 15.12% | 96.36% |
| 2012 | 7.70% | -127.70% |
| 2011 | -27.80% | -197.54% |
| 2010 | 28.50% | 94.14% |
| 2009 | 14.68% | 21.02% |
| 2008 | 12.13% | 15.30% |
| 2007 | 10.52% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 19.41% | -97.00% |
DE
|
|
| 19.68% | -96.96% |
DE
|
|
| 13.26% | -97.95% |
JP
|
|
| 17.08% | -97.36% |
CH
|
|
| 14.92% | -97.70% |
IL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Taiko Pharmaceutical Co.,Ltd.'s operating margin
What is Taiko Pharmaceutical Co.,Ltd.'s operating margin?
Taiko Pharmaceutical Co.,Ltd.'s operating margin is 6.48%, as of Nov 2026.
What was Taiko Pharmaceutical Co.,Ltd.'s operating margin in 2025?
In 2025, Taiko Pharmaceutical Co.,Ltd.'s operating margin was 7.18%, compared with 10.00% in 2024.
How has Taiko Pharmaceutical Co.,Ltd.'s operating margin changed since 2020?
From 2020 to 2025, Taiko Pharmaceutical Co.,Ltd.'s operating margin was highest in 2020 (31.96%) and lowest in 2022 (-61.09%).
How does Taiko Pharmaceutical Co.,Ltd.'s operating margin compare with similar companies?
Taiko Pharmaceutical Co.,Ltd.'s operating margin (6.48%) is lower than that of all 5 similar companies listed above. The highest among them is Merck KGaA, with 19.68%.